Literature DB >> 915310

Particle counting immunoassay (PACIA). I. A general method for the determination of antibodies, antigens, and haptens.

C L Cambiaso, A E Leek, F De Steenwinkel, J Billen, P L Masson.   

Abstract

By using a device designed for counting blood cells, it is possible to measure the agglutination of polystyrene beads (0.8 mu) with accuracy and great sensitivity, the agglutination resulting in a reduction in the number of particles. The latter coated with antigen can be used for determining IgM or IgG antibodies e.g. human rheumatoid factor or rabbit anti-bovine serum albumin antibodies. Macromolecules with multiple antigenic determinants agglutinate particles carrying specific antibodies. This system has been applied for determining HPL and alpha1-fetoprotein with a threshold of sensitivity of about 10 microgram/1. However the agglutination was decreased by serum factors which led to a 10-fold loss of sensitivity. The interference of rheumatoid factor which agglutinated the particles coated with rabbit or goat immunoglobulins could be avoided by reduction of the serum to be analyzed with 5mM dithiothreitol for 5 min. Haptens, i.e. DNP-lysine and T4, were determined by their inhibitory activities toward their specific antibodies, the agglutinator being a hapten-macromolecule conjugate or the antibodies themselves.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915310     DOI: 10.1016/0022-1759(77)90156-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  Characterization of an anti-idiotypic MoAb bearing an internal image of the receptor-binding epitope of cholera toxin.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Acetal-functionalized polymer particles useful for immunoassays. III: preparation of latex-protein complexes and their applications.

Authors:  R M Santos; J Forcada
Journal:  J Mater Sci Mater Med       Date:  2001-02       Impact factor: 3.896

3.  Latex agglutination assay of human immunoglobulin M antitoxoplasma antibodies which uses enzymatically treated antigen-coated particles.

Authors:  C L Cambiaso; L M Galanti; P Leautaud; P L Masson
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 4.  Aspects of measurement and analysis of regulatory peptides.

Authors:  J M Burrin; L O Uttenthal; G P McGregor; S R Bloom
Journal:  Experientia       Date:  1987-07-15

5.  Immune complexes in cord serum: influence of sex, gestational age, and Rh- blood group--possible predictive value of high levels for early postnatal infections.

Authors:  C M Farber; C L Cambiaso; P L Masson
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

6.  The clinical relevance of ferritin concentration in the cerebrospinal fluid.

Authors:  C J Sindic; D Collet-Cassart; C L Cambiaso; P L Masson; E C Laterre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

7.  Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid.

Authors:  C J Sindic; M P Chalon; C L Cambiaso; E C Laterre; P L Masson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

8.  The binding of myelin basic protein to the Fc region of aggregated IgG and to immune complexes.

Authors:  C J Sindic; C L Cambiaso; P L Masson; E C Laterre
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

9.  The elution of IgG from subacute sclerosing panencephalitis and multiple sclerosis brains.

Authors:  C J Sindic; C L Cambiaso; P L Masson; E C Laterre
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

10.  Protection of rat intestine against cholera toxin challenge by monoclonal anti-idiotypic antibody immunization via enteral and parenteral routes.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.